phenyl acetate has been researched along with Myocardial Infarction in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (29.23) | 18.7374 |
| 1990's | 17 (26.15) | 18.2507 |
| 2000's | 21 (32.31) | 29.6817 |
| 2010's | 5 (7.69) | 24.3611 |
| 2020's | 3 (4.62) | 2.80 |
| Authors | Studies |
|---|---|
| Bergner, C; David, R; Döring, P; Gäbel, R; Ince, H; Joksch, M; Krause, BJ; Kurth, J; Lang, CI; Lemcke, H; Lindner, T; Müller, P; Steinhoff, G; Stenzel, J; Vasudevan, P; Vollmar, B; Wester, HJ | 1 |
| Annor, T; Brits, B; Hlongwa, KN; Lawal, I; Mahapane, J; Maserumule, LC; Mokoala, K; Ndlovu, H; Sathekge, M; Vorster, M | 1 |
| Bom, HS; Cho, SG; Jeong, MH; Kim, Y | 1 |
| Wardak, M | 1 |
| Kastelein, JJP; Lincoff, AM; Mani, P; Menon, V; Nicholls, SJ; Nissen, SE; Puri, R; Schwartz, GG; Shao, M | 1 |
| Bash, D; Brennan, DM; Cavender, MA; Jukema, JW; Kastelein, JJ; Koenig, W; Lincoff, AM; Menon, V; Nambi, V; Nicholls, SJ; Nissen, SE; Rosenson, RS; Schwartz, GG; Wright, RS | 1 |
| O'Donoghue, ML | 1 |
| Beanlands, RS; Croteau, E; DaSilva, JN; deKemp, RA; Klein, R; McDonald, M; Renaud, JM | 1 |
| Berger, PB; Blankenship, JC; Hubbard, CR; Scott, TD; Skelding, KA | 1 |
| Fujibayashi, Y; Hussain, R; Kobayashi, M; Kudo, T; Okazawa, H; Tsujikawa, T | 1 |
| Paret, CL | 1 |
| Beanlands, RS; Katoh, C; Kitabatake, A; Komuro, K; Kuge, Y; Morita, K; Noriyasu, K; Tamaki, N; Yamada, S; Yoshinaga, K | 1 |
| Califf, RM; Crater, SW; Giugliano, RP; Green, CL; Harrington, RA; Johanson, P; Krucoff, MW; Langer, A; Lincoff, AM; Newby, LK; Rebeiz, AG; Roe, MT; Topol, EJ; Wagner, GS | 1 |
| Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC | 1 |
| Nayak, SG; Satish, R | 1 |
| Fujioka, D; Hanasaki, K; Ishimoto, Y; Kanazawa, M; Kawabata, K; Kobayashi, T; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Suzuki, N; Tezuka, H; Yano, T; Yokota, Y | 1 |
| Al-Hassan, SS; Al-Mudhaffar, SA; Shakib, MI | 1 |
| Schwaiger, M; von Schulthess, GK | 1 |
| Fujita, M; Hata, T; Hosokawa, R; Konishi, J; Kudo, T; Lee, L; Nohara, R; Sasayama, S; Tadamura, E; Tamaki, N | 1 |
| Bergmann, SR; Dávila-Román, VG; Geltman, EM; Gropler, RJ; Lee, DS; Rubin, PJ; Schechtman, KB | 1 |
| Burchert, W; Lichtlen, PR; Meyer, GJ; van den Hoff, J; Weinhardt, R; Wolpers, HG | 1 |
| Gawaz, M; Neumann, FJ; Schömig, A | 1 |
| Rossi, G | 1 |
| Adgey, AA | 1 |
| Armstrong, PW; Braunwald, E; Califf, RM; Gibler, WB; Hamm, CW; Maseri, A; Simoons, ML; Van de Werf, F | 1 |
| Akita, S; Hashimoto, T; Iida, A; Narita, N; Ohte, N | 1 |
| Bates, ER | 1 |
| Greenbaum, AB; Harrington, RA; Hudson, MP; Ohman, EM | 1 |
| Chanu, B | 1 |
| Phillips, J; Stouffer, GA; Subbarao, VD | 1 |
| White, HD | 1 |
| Moliterno, DJ | 1 |
| Califf, RM; Lincoff, AM; Topol, EJ | 1 |
| Jang, IK; Sabatine, MS | 1 |
| Mak, KH; Moliterno, DJ | 1 |
| Flamen, PB; Kuzo, RS; Maes, AF; Mesotten, LV; Mortelmans, L; Nuyts, JL; Van de Werf, F | 1 |
| Goto, S; Handa, M; Ikeda, Y; Murata, M | 1 |
| Iida, H; Katoh, C; Knuuti, J; Lehikoinen, P; Någren, K; Sipilä, H; Ukkonen, H; Voipio-Pulkki, LM | 1 |
| Bode, C; Nordt, TK; Peter, K | 1 |
| Boden, WE; McKay, RG | 1 |
| Barrabés, JA; Blanco, J; Garcia-Dorado, D; Lidón, RM; Mirabet, M; Pizcueta, P; Puigfel, Y; Ruiz-Meana, M; Soler-Soler, J; Soriano, B | 1 |
| Maes, A; Mesotten, L; Mortelmans, L; Van de Werf, F | 1 |
| Akita, S; Hayano, J; Iida, A; Kimura, G; Kurokawa, K; Miyabe, H; Narita, H; Ohte, N; Yajima, K | 1 |
| Greco, V; Jacobellis, GF; Pozzar, F; Puletti, M | 1 |
| Glubokov, DA; Iakushev, VS; Lifshits, RI | 1 |
| Bol, A; Cogneau, M; Labar, D; Melin, JA; Michel, C; Robert, A; Vanbutsele, R; Vanoverschelde, JL; Wijns, W | 1 |
| Bergmann, SR; Brown, MA; Geltman, EM; Henes, CG; Sobel, BE; Walsh, MN; Weinheimer, CJ | 1 |
| Bender, H; Beyerle, R; Bohn, H; Martorana, PA; Schönafinger, K | 1 |
| Dinu, IV; Hristea, R | 1 |
| Abelmann, WH; Blatt, WF; Mager, M | 1 |
| Di Giorgio, J | 1 |
| Bing, RJ; Braasch, W; Cowan, C; Gudbjarnason, S | 1 |
| Kronrád, L; Petrboková, I; Vavrejn, B | 1 |
| Arora, RB; Das, D; Kapoor, SC; Sharma, RC | 1 |
| Kozák, P | 1 |
| Efimenko, GP; Iakushev, VS; Lifshits, RI; Slobodin, VB | 1 |
| Avezou, F; Denis, B; Mallion, JM; Martin-Noel, P | 1 |
| Artuso, P; Chierici, F; Suriani, L | 1 |
| Fredrickson, DS; Glueck, CJ; Levy, RI | 1 |
| Bajolle, F; Borel, JP; Deville, A | 1 |
| Blankenhorn, DH; Chin, HP | 1 |
| Koskelo, P; Toivonen, I | 1 |
15 review(s) available for phenyl acetate and Myocardial Infarction
| Article | Year |
|---|---|
[Clinical indications for PET of the heart].
Topics: Acetates; Cardiomyopathies; Coronary Disease; Deoxyglucose; Fatty Acids; Fluorodeoxyglucose F18; Humans; Myocardial Infarction; Myocardium; Tomography, Emission-Computed | 1993 |
[Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease].
Topics: Abciximab; Acetates; Alkynes; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Binding Sites; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Coronary Disease; Double-Blind Method; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Randomized Controlled Trials as Topic; Receptors, Antigen, B-Cell; Receptors, Cell Surface; Time Factors; Tirofiban; Tyrosine | 1997 |
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
Platelet glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction.
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Blood Coagulation; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Treatment Outcome; Tyrosine | 1998 |
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.
Topics: Abciximab; Acetates; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Tyrosine | 1999 |
Use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Angina, Unstable; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 1999 |
Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies?
Topics: Acetates; Angina, Unstable; Anticoagulants; Confidence Intervals; Controlled Clinical Trials as Topic; Enoxaparin; Female; Humans; Male; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Survival Rate; Treatment Outcome; Tyrosine | 2000 |
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Combined Modality Therapy; Coronary Disease; Drug Monitoring; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Recurrence; Risk Factors; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine | 2000 |
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes.
Topics: Acetates; Acute Disease; Eptifibatide; Hemorrhage; Humans; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Tirofiban; Tyrosine | 1999 |
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor | 2000 |
[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct].
Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tyrosine | 2001 |
Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non-ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials.
Topics: Acetates; Clinical Trials as Topic; Electrocardiography; Eptifibatide; Heart Conduction System; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey.
Topics: Acetates; Ammonia; Carbon Radioisotopes; Fluorodeoxyglucose F18; Myocardial Infarction; Nitrogen Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
9 trial(s) available for phenyl acetate and Myocardial Infarction
| Article | Year |
|---|---|
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Australia; C-Reactive Protein; Death; Europe; Female; Humans; India; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; New Zealand; North America; Phospholipase A2 Inhibitors; Placebos; Risk Factors; Stroke; Treatment Outcome | 2019 |
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Atherosclerosis; Atorvastatin; Double-Blind Method; Early Termination of Clinical Trials; Female; Heptanoic Acids; Humans; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2, Secretory; Pyrroles; Risk; Stroke; Survival Analysis; Treatment Outcome | 2014 |
Reduced oxidative metabolic response in dysfunctional myocardium with preserved glucose metabolism but with impaired contractile reserve.
Topics: Acetates; Carbon; Female; Glucose; Heart; Humans; Male; Metabolic Clearance Rate; Middle Aged; Myocardial Infarction; Myocardial Stunning; Myocardium; Oxygen; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Gl
Topics: Acetates; Aged; Angina, Unstable; Anticoagulants; Aspirin; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Analysis; Tyrosine | 1998 |
Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial.
Topics: Acetates; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Treatment Outcome; Tyrosine | 1998 |
[Inhibitors of GPIIb/IIIa platelet receptors].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Cerebrovascular Disorders; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine | 1999 |
Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee.
Topics: Acetates; Adult; Aged; Cohort Studies; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Rate; Tyrosine | 2000 |
Use of [11C]acetate and [15O]O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction.
Topics: Acetates; Aged; Carbon Radioisotopes; Chronic Disease; Coronary Circulation; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Oxygen Consumption; Oxygen Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes.
Topics: Acetates; Acute Disease; Aged; Coronary Disease; Double-Blind Method; Endpoint Determination; Female; Hemorrhage; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Titrimetry; Treatment Outcome; Tyrosine | 2002 |
41 other study(ies) available for phenyl acetate and Myocardial Infarction
| Article | Year |
|---|---|
[
Topics: Acetates; Animals; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mice; Myocardial Infarction; Neovascularization, Physiologic; Oligopeptides; Positron-Emission Tomography; Stem Cell Transplantation; Ventricular Remodeling | 2020 |
Imaging dysregulated calcium homeostasis in acute myocardial infarction with [
Topics: Acetates; Calcium; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Homeostasis; Humans; Myocardial Infarction; Positron-Emission Tomography | 2021 |
Myocardial Infarction With Nonobstructive Coronary Arteries Assessed by 11C-Acetate Cardiac PET.
Topics: Acetates; Carbon Radioisotopes; Coronary Circulation; Coronary Vessels; Humans; Male; Middle Aged; Myocardial Infarction; Positron-Emission Tomography | 2019 |
Topics: Acetates; Animals; Exenatide; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; Heterocyclic Compounds, 1-Ring; Humans; Laboratories; Lizards; Myocardial Infarction; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
Acute coronary syndromes: targeting inflammation-what has the VISTA-16 trial taught us?
Topics: Acetates; Acute Coronary Syndrome; Female; Humans; Indoles; Male; Myocardial Infarction; Phospholipases A | 2014 |
Test-retest repeatability of myocardial blood flow and infarct size using ¹¹C-acetate micro-PET imaging in mice.
Topics: Acetates; Animals; Blood Flow Velocity; Carbon Radioisotopes; Coronary Circulation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Emergency pretreatment for contrast allergy before direct percutaneous coronary intervention for ST-elevation myocardial infarction.
Topics: Acetates; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Antiemetics; Cimetidine; Contrast Media; Cyclopropanes; Drug Hypersensitivity; Drug Therapy, Combination; Emergency Medical Services; Heart Conduction System; Histamine H2 Antagonists; Humans; Leukotriene Antagonists; Methylprednisolone; Myocardial Infarction; Prochlorperazine; Quinolines; Sulfides; Time Factors | 2008 |
Validation of the calculation of the clearance rate constant (k(mono)) of [(11)C]acetate using parametric k(mono) image for myocardial oxidative metabolism.
Topics: Acetates; Adult; Aged; Carbon; Female; Heart; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Myocardial Infarction; Myocardium; Oxygen; Oxygen Consumption; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Topics: Acetates; Calcium; Calcium Compounds; Coronary Artery Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
Topics: Abciximab; Acetates; Aged; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Streptokinase; Survival Analysis; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine | 2005 |
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional | 2007 |
An unusual toxic cause of hemolytic-uremic syndrome.
Topics: Acetates; Blood Component Transfusion; Fatal Outcome; Hemolytic-Uremic Syndrome; Herbicides; Humans; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Renal Insufficiency; Suicide, Attempted | 2007 |
Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice.
Topics: Acetates; Animals; Arachidonic Acid; Cells, Cultured; Chemotaxis, Leukocyte; Echocardiography; Enzyme Inhibitors; Group X Phospholipases A2; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Neutrophils; Peroxidase; Prodrugs; Reactive Oxygen Species | 2008 |
Isoelectric focusing, and other physical, kinetic properties of GOT isoenzymes isolated from sera of myocardial infarction patients.
Topics: Acetates; Aspartate Aminotransferases; Aspartic Acid; Calcium; Female; Fumarates; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing; Isoenzymes; Kinetics; Magnesium; Male; Molecular Weight; Myocardial Infarction; Spectrophotometry; Temperature | 1980 |
Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion.
Topics: Acetates; Adult; Aged; Carbon Radioisotopes; Cardiac Catheterization; Coronary Angiography; Coronary Circulation; Dobutamine; Echocardiography; Female; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Oxidation-Reduction; Tomography, Emission-Computed; Ventricular Function, Left | 1996 |
Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction.
Topics: Acetates; Adult; Aged; Carbon Radioisotopes; Chronic Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Oxygen Consumption; Predictive Value of Tests; Systole; Tomography, Emission-Computed; Ventricular Function, Left | 1996 |
Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction.
Topics: Acetates; Aged; Carbon Isotopes; Coronary Circulation; Differential Threshold; Heart; Humans; Middle Aged; Myocardial Infarction; Myocardium; Predictive Value of Tests; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
[Superaspirin in the platelet aggregation inhibitor therapy].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine | 1997 |
Extent of myocardial damage in regions with reverse redistribution at 3 h and at 24 h on 201Tl SPET: evaluation based on regional myocardial oxidative metabolism.
Topics: Acetates; Aged; Carbon Radioisotopes; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Oxidation-Reduction; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate.
Topics: Acetates; Adult; Aged; Carbon Radioisotopes; Coronary Circulation; Energy Metabolism; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Predictive Value of Tests; Radionuclide Angiography; Thrombolytic Therapy; Tomography, Emission-Computed | 2001 |
Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs.
Topics: Acetates; Animals; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; Neutrophils; Peroxidase; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; Tyrosine | 2002 |
Myocardial oxidative metabolism in remote normal regions in the left ventricles with remodeling after myocardial infarction: effect of beta-adrenoceptor blockers.
Topics: Acetates; Adrenergic beta-Antagonists; Atenolol; Carbon Radioisotopes; Cardiac Catheterization; Case-Control Studies; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Myocardium; Oxygen Consumption; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling | 2002 |
Acid gas-induced MI.
Topics: Acetates; Acute Disease; Ammonia; Gas Poisoning; Humans; Male; Middle Aged; Myocardial Infarction | 1978 |
[Use of Na1C14 acetate for biosynthesis of serum and organ lipid components in the early periods of experimental myocardial ischemia].
Topics: Acetates; Animals; Lipids; Myocardial Infarction; Organ Specificity; Rabbits | 1976 |
Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake.
Topics: Acetates; Adult; Aged; Coronary Circulation; Female; Glucose; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Oxidation-Reduction; Tomography, Emission-Computed | 1992 |
Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction.
Topics: Acetates; Adult; Animals; Carbon Radioisotopes; Dogs; Half-Life; Heart; Hemodynamics; Humans; Male; Myocardial Infarction; Myocardium; Oxygen; Oxygen Consumption; Tomography, Emission-Computed | 1989 |
[New cardiovascular acting 2-aryl-2-imidazolinyl-acetic acids. Synthesis and pharmacologic effects].
Topics: Acetates; Animals; Blood Pressure; Cardiovascular Agents; Chemical Phenomena; Chemistry; Ganglionic Blockers; Heart Rate; Hemodynamics; Imidazoles; Male; Myocardial Infarction; Rats; Receptors, Adrenergic, alpha; Spinal Cord | 1985 |
[Uranyl-resistant paraproteins. Immunochemical method of identification of pathological protein fractions].
Topics: Acetates; Arteriosclerosis Obliterans; Benzene; Blood Protein Disorders; Blood Proteins; gamma-Globulins; Humans; Hypersensitivity; Immunoelectrophoresis; Immunoglobulins; Liver Cirrhosis; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myocardial Infarction; Uranium | 1970 |
The use of cellulose acetate for the electrophoretic separation and quantitation of serum lactic dehydrogenase isozymes in normal and pathologic states.
Topics: Acetates; Adult; Aged; Cellulose; Diagnosis, Differential; Electrophoresis; Female; Humans; Isoenzymes; L-Lactate Dehydrogenase; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Pneumonia; Pulmonary Embolism; Staining and Labeling | 1966 |
Determination of serum lactic dehydrogenase isoenzymes by use of the "Diagnostest" cellulose acetate electrophoresis system.
Topics: 1-Propanol; Acetates; Azo Compounds; Cellulose; Coloring Agents; Densitometry; Dimethyl Sulfoxide; Electrophoresis; Female; Hepatitis A; Humans; Indicators and Reagents; Isoenzymes; L-Lactate Dehydrogenase; Lactates; Male; Methods; Myocardial Infarction; NAD; Phenazines; Sulfuric Acids; Tetrazolium Salts | 1971 |
Metabolism of infarcted heart muscle during tissue repair.
Topics: Acetates; Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Carbon Dioxide; Carbon Isotopes; Dogs; Fructose-Bisphosphate Aldolase; Glucose; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Ventricles; In Vitro Techniques; Isocitrate Dehydrogenase; L-Lactate Dehydrogenase; Lactates; Lipids; Malate Dehydrogenase; Myocardial Infarction; Myocardium; NAD; NADP; Spectrophotometry | 1968 |
Distribution and behaviour of various labelled mercury compounds in the organism. 3. Accumulation of mercuritetracycline, mercuric acetate and chlormerodrin in damaged muscle and tumour.
Topics: Acetates; Animals; Carcinoma 256, Walker; Mercury; Muscles; Myocardial Infarction; Organomercury Compounds; Radionuclide Imaging; Rats; Tetracycline; Time Factors | 1973 |
Effect of some fractions of Commiphora mukul on various serum lipid levels in hypercholesterolemic chicks and their effectiveness in myocardial infarction in rats.
Topics: Acetates; Alkanes; Animals; Chickens; Hypercholesterolemia; Lipids; Myocardial Infarction; Petroleum; Plant Extracts; Plants, Medicinal; Rats | 1973 |
[Cardiac effect of a new penta-acetylated gitoxin (pengitoxin)].
Topics: Acetates; Aged; Digitalis Glycosides; Female; Heart Auscultation; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Infarction; Phonocardiography | 1974 |
[Radioisotope indication of metabolic processes in the myocardium and liver during the acute period of experimental myocardial ischemia].
Topics: Acetates; Amino Acids; Animals; Aspartic Acid; Carbon Radioisotopes; Glucose; Liver; Myocardial Infarction; Myocardium; Oxidation-Reduction; Pyruvates; Sodium | 1974 |
[Study of the action of Vibeline 100 on coronary angor].
Topics: Acetates; Aged; Angina Pectoris; Benzopyrans; Butyrates; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1971 |
[Clinical results of the use of a new drug association in heart diseases].
Topics: Acetates; Adult; Aged; Amobarbital; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pentaerythritol Tetranitrate; Propylamines | 1970 |
Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons.
Topics: Acetates; Adolescent; Adult; Blood Protein Disorders; Diet; Electrocardiography; Electrophoresis; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Heparin; Humans; Hydrolases; Hyperlipidemias; Hypoglycemic Agents; Insulin; Lipase; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Norethindrone; Pancreatitis; Sex Factors; Triglycerides | 1971 |
[Electrophoresis of lactic dehydrogenase (L.D.H.) isoenzymes on cellulose acetate. Technic and results].
Topics: Acetates; Animals; Cellulose; Coronary Disease; Electrophoresis; Heart Diseases; Isoenzymes; L-Lactate Dehydrogenase; Liver Cirrhosis; Liver Neoplasms; Methods; Muscles; Myocardial Infarction; Rabbits | 1968 |
On the precision of lipoprotein electrophoresis on cellulose acetate and its use in the diagnosis of hyperlipoproteinemia.
Topics: Acetates; Adult; Blood Protein Disorders; Cellulose; Coronary Disease; Electrophoresis; Fasting; Female; Humans; Lipoproteins; Male; Methods; Myocardial Infarction; Time Factors | 1969 |
Separation of urinary coproporphyrin isomers 1 and 3 by thin-layer chromatography. Studies in healthy subjects and patients with myocardial infarction.
Topics: Acetates; Adolescent; Adult; Aged; Buffers; Chromatography, Paper; Chromatography, Thin Layer; Female; Humans; Indicators and Reagents; Male; Middle Aged; Myocardial Infarction; Porphyrins; Solvents | 1966 |